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Abstract: The aim of this study was to optimise the experimental conditions for the 
synthesis of silica nanoparticles. In achieving this, the amount of butanol, the amount of 
surfactant, the amount of silica precursor, the synthesis temperature and the agitation 
speed were optimised by applying the Taguchi orthogonal arrays method. The optimal 
synthesis conditions for silica nanoparticle production were a temperature of 50°C, 6 ml 
butanol, 7 ml Tween 80, 3 ml trimethoxyvinylsilane (TMVS), and an agitation speed of 
320 rpm. The nanoparticle size was characterised to optimise the synthesis conditions 
and determined to be smaller than 100 nm using a Malvern Zetasizer Nano ZS and a 
transmission electron microscope (TEM).   
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1. INTRODUCTION 
 
Over the past decades, the drug delivery system (DDS) concept has made 
great progress in the treatment of a variety of diseases and in cancer therapy. 
Some of the most important aspects of DDS include high stability in biological 
media, high carrier capacity, potential use for both hydrophilic and hydrophobic 
molecules, tuneable size for targeted delivery and controllable release of 
molecules. Nanoparticles for DDS are typically made of biocompatible and 
biodegradable materials such as polymers and ceramics. Ceramic nanoparticles 
such as those composed of silica have attracted much attention in recent years 
due to their unique properties, which include biocompatibility, chemical and 
mechanical stability, large specific surface area, and porous structure.1–4  
 
The properties of silica nanoparticles are affected by various parameters 
such as the reaction temperature, butanol concentration, surfactant type, silica 
precursor and agitation speed used during synthesis.5,6 The interaction between 
these variables is complex; therefore, the analysis of this system to optimise the 
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processing conditions is time and labour intensive. The use of Taguchi method 
makes it possible to develop an acceptable formulation using minimum raw 
materials and save time. The primary goal of Taguchi method is to analyse all 
variables simultaneously using a few experiments. Software that implements this 
method can be successfully utilised to optimise various formulations within a 
given set of independent variables.7–10 
 
In this study, the micelle entrapment approach was used to synthesise 
silica nanoparticles as nano-carriers for DDS, and the essential parameters were 
considered. The objectives of this work were to optimise the experimental 
conditions for the preparation of silica nanoparticles and to select the significant 
parameters that most strongly affect the nanoparticle size by the Taguchi design 
method. In addition, the nanoparticle size was evaluated by dynamic light 
scattering (DLS), and transmission electron microscopy (TEM) was used to 
characterise the size and shape of the silica nanoparticles for DDS.  
 
 
2. EXPERIMENTAL 
 
2.1 Materials 
 
 The materials required for the synthesis of silica nanoparticles were as 
follows. Tween 80-viscous liquid, trimethoxyvinylsilane (TMVS 98% pure) and 
rifampicin were obtained from Sigma-Aldrich Co. (Missouri, U.S.). 2-Butanol 
(99% pure) and a 10 M ammonium hydroxide solution (31.5% NH3 pure) were 
obtained from Fischer Scientific (Fairlawn, New Jersey, U.S.). All chemicals 
were of analytical grade and used without any purification. De-ionised water 
from a Millipore filtration system (with a conductivity of 18.2 MΩ cm) was used 
in this study.  
 
2.2 Sample Preparation  
 
 Silica nanoparticles were prepared via the micelle formation approach. 
First, 5.5 ml Tween 80 was dissolved in 200 ml of de-ionised water. The mixture 
was stirred for 15 min before 200 μl of prepared NH3 (1 ml NH3 was dissolved in 
1 ml de-ionised water) was added to ensure the pH was maintained within the 
range of 9–11. Then, butanol was poured into the mixture and continuously 
stirred for 5 min. The mixture was then transferred into a preheated reactor at a 
set temperature and continuously stirred at 320 rpm for 1 h. A prepared 
rifampicin drug solution (839 mg of rifampicin dissolved in 1.5 ml methanol) 
was then added to the abovementioned mixture and continuously stirred under 
the same conditions. After an hour, TMVS was added as a silica precursor. The 
mixture was continuously stirred overnight at 320 rpm and maintained at a set 
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temperature, which yielded a total volume of 250 ml. The produced silica was 
then subjected to dialysis for 5 days to remove the surfactant. Finally, the sample 
was collected in a bottle and stored in a refrigerator until further testing. 
 
2.3 Characterisation 
 
The synthesised silica nanoparticles were characterised using different 
techniques. The particle size was characterised by dynamic light scattering 
(Zetasizer Nano ZS, Malvern Instrument, U.K.), whereas images of the samples 
were captured using transmission electron microscopy (TEM; Philips, model 
CM12, Eindhoven, Netherlands). To prepare samples for TEM observation, a 
drop of silica nanoparticles was placed on a copper grid coated with carbon and 
air-dried for 3 min at room temperature. Then, the grid was examined by TEM 
without being stained. 
 
2.4 Experimental Design  
 
A specialised experimental design was used to develop an optimisation 
process for silica nanoparticle preparation. In this study, the Taguchi orthogonal 
arrays (OA) method was used to identify the optimal conditions and to select the 
synthesis parameters that have the most significant effect on the size of silica 
nanoparticles. To minimise the number of experiments, Taguchi OA was 
implemented using Design Expert statistical software version 8.0.6.1 (Stat-Ease, 
Inc., Minneapolis, U.S.). Taguchi OA was applied by choosing 5 parameters that 
could affect the size of silica nanoparticles. The levels of each parameter are 
listed in Table 1. The orthogonal arrays of the L16 type were used, indicating that 
16 experiments were required to study all of the parameters involved, with the 
target output parameter being the particle size (particle diameter in nanometres), 
as shown in Table 2. 
 
Table 1: Factors and levels employed in Taguchi method. 
 
Code Factor 
Level 
1 2 3 4 
A Temperature (°C) 40 50 60 70 
B Amount of 2-butanol (ml) 4 6 8 10 
C Amount of Tween 80 (ml) 3 5 7 9 
D Amount of TMVS (ml) 1 2 3 4 
E Agitation speed (rpm) 220 320 420 520 
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Table 2:  Combination of variables of the Taguchi orthogonal experimental design (16 
runs [4 levels and 5 factors]). 
 
Run 
A 
Temperature 
B 
2-Butanol 
C 
Tween 80 
D 
TMVS 
E 
Agitation 
speed 
Average 
particle 
size (nm) 
S/N ratio 
(dB) 
1 40 4 3 1 220 18.24 –25.22 
2 40 6 5 2 320 31.22 –29.89 
3 40 8 7 3 420 60.45 –35.63 
4 40 10 9 4 520 101.53 –40.13 
5 50 4 7 2 520 45.81 –33.22 
6 50 6 9 1 420 63.66 –36.08 
7 50 8 3 4 320 54.37 –34.71 
8 50 10 5 3 220 68.98 –36.77 
9 60 4 9 3 320 95.68 –39.17 
10 60 6 7 4 220 111.47 –40.94 
11 60 8 5 1 520 46.47 –33.34 
12 60 10 3 2 420 87.74 –38.86 
13 70 4 5 4 420 126.87 –42.07 
14 70 6 3 3 520 69.69 –36.86 
15 70 8 9 2 220 115.30 –41.24 
16 70 10 7 1 320 89.54 –39.04 
 
 
3. RESULTS AND DISCUSSION 
 
3.1  Analysis of Experimental Design 
 
An OA design was used to identify the optimal conditions and to select 
the parameters that have the greatest effect on the size of silica nanoparticles. 16 
experiments were performed to estimate the best conditions for the synthesis of 
the nanoparticles. The structure of the OA design and the results of particle size 
measurements are shown in Table 2, and the smallest nanoparticle size (18.24 
nm) is presented in run number 1. The particle size for each sample of silica 
nanoparticles was determined by DLS. Experiments were performed for each run 
number in Table 2. 
 
In the Taguchi method, the signal/noise (S/N) ratio is a measure of signal 
quality and deviation from the desired value. The term "signal" represents the 
desired value (mean), whereas "noise" represents an undesired value (standard 
deviation from mean) for output characteristics.11 The S/N ratio varies with the 
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type of characteristic considered. A "smaller-the-better" type of S/N ratio is used 
in analyses aimed at achieving high accuracy. This type of S/N ratio is defined as 
follows: 
 
S/N ratio [dB] = –10 log [y12 + y22 + y32 + …. /n] 
 
Table 2 shows the S/N ratio for each particle size calculated by the 
above-described equation, and the results of particle size measurements 
performed by DLS. The mean S/N ratio for each level of the parameters and the 
response in terms of the S/N ratio is shown in Table 3. The highest value of A 
indicates that temperature has the most significant effect on the size of silica 
nanoparticles. The amount of TMVS has the second most significant effect on 
nanoparticle size, and the agitation speed has the weakest effect.  
  
Table 3: S/N response table for silica nanoparticle size. 
 
Factors 
Mean S/N ratio (dB) for particle size 
Contribution (%) 
Level 1 Level 2 Level 3 Level 4 
A –32.72 –35.19 –38.19 –39.80 28.92 
B –35.03 –35.94 –36.23 –38.70 14.99 
C –33.91 –35.52 –37.21 –39.27 21.85 
D –33.42 –35.80 –37.22 –39.46 24.66 
E –36.04 –35.81 –38.16 –35.89 9.58 
 
Table 4 shows the main effects of the various factors on the size of silica 
nanoparticles. The Model F-value of 4.64 implies the model is significant. There 
is only a 2.02% chance that such a large Model F-value could occur due to noise. 
Values of "Prob > F" less than 0.0500 indicate that the model terms are 
significant. Therefore, based on the results presented in Table 3 and Table 4, A 
and C, which represent temperature and the amount of TMVS, are significant 
model terms, and the R-squared value is equal to 0.7558.   
 
Table 4: ANOVA table of silica nanoparticle size. 
 
Sources Degrees of freedom Sum of squares F-value 
p-value 
prob > F 
Model 6 0.72 4.64 0.0202 
A – Temperature 3 0.35 4.52 0.0339 
D – TMVS 3 0.37 4.76 0.0296 
Residual  9 0.23 – – 
Cor total 15 0.95 – – 
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The response graphs corresponding to the aforementioned factors are 
presented in Figure 1. As shown in the figure, the optimal conditions for the 
synthesis of silica nanoparticles are a temperature at level 2, an amount of 2-
butanol at level 2, an amount of Tween 80 at level 3, an amount of TMVS at 
level 3, and an agitation speed at level 2.  
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Figure 1: Response graph of S/N ratio for smaller-the-better analysis of nanoparticle size. 
 
The following were determined to be the best parameters for the 
production of silica nanoparticles: temperature = 50°C; amount of 2-butanol = 6 
ml; amount of Tween 80 = 7 ml; amount of TMVS = 3 ml; and agitation speed = 
320 rpm. Under these conditions, the software program estimated the 
nanoparticle size to be 32.07 nm, whereas the nanoparticle size achieved by 
experiment was 28.91 nm, as shown in Figure 2. Experiments were conducted to 
validate the optimal parameters obtained by the Taguchi method. Good 
agreement was observed between the predicted particle size and the experimental 
particle size. Consequently, the size of synthesised silica nanoparticles can be 
improved through the Taguchi method.  
 
3.2 Characteristics and Determination of Silica Nanoparticle Size 
Distribution 
 
TEM micrographs and the particle size distribution of the silica 
nanoparticles obtained under optimal conditions are shown in Figure 2. Silica 
nanoparticles with a mean size of 28.91 nm were prepared, as illustrated in Figure 
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2 (a). It was observed that the size distribution of the prepared silica nanoparticles 
was unimodal and uniform. The average diameter of the silica particles, which 
were nearly spherical, was determined based on the diameter of approximately 
100 particles using TEM micrographs of a sample, as illustrated in Figure 2 (b).  
 
  
(a) (b) 
 
Figure 2:  TEM image (a) and histogram of particle size distribution (b) of silica 
nanoparticles obtained under optimal conditions. 
 
         
4.  CONCLUSION    
 
 This study demonstrated that the size of silica nanoparticles entrapped 
with rifampicin synthesised by the micelle entrapment approach can be 
manipulated by varying the process conditions. Using the Taguchi method, 
parameter A (temperature) was determined to have the most significant effect in 
tuning the size of silica nanoparticles. Based on the S/N ratio and ANOVA, the 
optimum conditions for preparing silica nanoparticles are a temperature of 50°C, 
6 ml 2-butanol, 7 ml Tween 80, 3 ml trimethoxyvinylsilane (TMVS), and an 
agitation speed of 320 rpm. Under these conditions, silica nanoparticles 
measuring 28.91 nm were produced. This study shows that the Taguchi method is 
one of the most suitable methods for optimising experimental conditions to 
achieve the minimum size of silica nanoparticles for drug delivery systems.  
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